Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Sen. Bob Menendez

Sens. Menendez and Booker, Reps. Gottheimer and Pascrell Announce $363,583 Grant for Hackensack University Medical Center

Washington, DC, September 8, 2017 — Senators Bob Menendez and Cory Booker and Congressmen Bill Pascrell (NJ-8) and Josh Gottheimer (NJ-5) announced on September 7 that Hackensack University Medical Center in collaboration with the Stevens Institute of Technology will be receiving $363,583 in federal funds for cancer treatment research from the U.S. Department of Health and Human Services’ National Cancer Institute.

“Thanks to Hackensack UMC’s John Theurer Cancer Center, North Jersey is a key player in the battle against cancer. I’m hopeful that their path-breaking research will one day overcome multiple myeloma cells,” said Congressman Josh Gottheimer (NJ-5). Continue reading

Sen. Menendez Visits Rutgers Cancer Institute to Illustrate Impact of Trump Proposed Budget Cuts on Lifesaving Biomedical Research that Leads to New Cures, Treatments

Sen. Bob Menendez and (l.) Dr. Steven Libutti

New Brunswick, NJ, April 13, 2017 — During a visit yesterday to the Rutgers Cancer Institute of New Jersey, U.S. Senator Bob Menendez and several of the state’s top biomedical researchers and experts, outlined the devastating impact the Trump Administration’s proposed budget cuts to the National Institutes of Health (NIH) would have on lifesaving biomedical research, and treatments of diseases and neurological disorders.

New Jersey is the nation’s second largest recipient of NIH funding in the nation.

“A budget is a reflection of priorities,” said Sen. Menendez.  “The cuts proposed by the Trump Administration send a message that the research being done right here by some of nation’s most brilliant minds is not a priority.”

“It says the breakthrough discoveries that could potentially help someone like my mother in her fight against Alzheimer’s or give a terminally-ill child a shot at a healthy, happy life – is not worthy of federal investment,” Menendez added.  “That’s not a message I want to send.” Continue reading